Page last updated: 2024-09-03

phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and oxymorphone

phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with oxymorphone in 1 studies

Compound Research Comparison

Studies
(phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide)
Trials
(phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide)
Recent Studies (post-2010)
(phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide)
Studies
(oxymorphone)
Trials
(oxymorphone)
Recent Studies (post-2010) (oxymorphone)
27605553282129

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cador, M; Marco, N; Simonnet, G; Stinus, L1

Other Studies

1 other study(ies) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and oxymorphone

ArticleYear
Interaction between neuropeptide FF and opioids in the ventral tegmental area in the behavioral response to novelty.
    Neuroscience, 2002, Volume: 110, Issue:2

    Topics: Analgesics, Opioid; Animals; Behavior, Animal; Dopamine; Dose-Response Relationship, Drug; Environment, Controlled; Exploratory Behavior; Male; Motor Activity; Neurons; Oligopeptides; Opioid Peptides; Oxymorphone; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Thiorphan; Ventral Tegmental Area

2002